Announcements
Trials
Browse
Landscape
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasm Metastasis
×
osimertinib
×
Tumor-Agnostic
×
Clear all
Filters
3
NCT05261399
2026-04-06
SAFFRON
AstraZeneca
Phase 3
Active not recruiting
345 enrolled